Prognostic factors for survival after autologous and allogeneic stem cell transplantation for Chronic Lymphocytic Leukemia (CLL): The EBMT experience

被引：0
|
作者：
Michallet, M
Brand, R
Dreger, P
Milligan, DW
Esteve, J
Kimby, E
Gratwohl, A
Apperley, J
Van Biezen, A
Niederwieser, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] Impact on Progression Free Survival of Autologous Stem Cell transplantation after Consolidation with Alemtuzumab in Chronic Lymphocytic Leukemia
    Montillo, Marco
    Ricci, Francesca
    Tedeschi, Alessandra
    Miqueleiz, Sara
    Grillo, Giovanni
    Vismara, Eleonora
    Greco, Antonino
    Veronese, Silvio
    Morra, Enrica
    [J]. BLOOD, 2008, 112 (11) : 761 - 761
  • [42] Rituxan in vivo purging of stem cells for autologous transplantation in chronic lymphocytic leukemia (CLL).
    Berkahn, LC
    Simpson, DR
    Raptis, A
    Pavletic, S
    Klingemann, HG
    [J]. BLOOD, 2000, 96 (11) : 186A - 186A
  • [43] Different clinical value of minimal residual disease after autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    Esteve, J
    Villamor, N
    Colomer, D
    Montserrat, E
    [J]. BLOOD, 2002, 99 (05) : 1873 - 1874
  • [44] Follow-up of chronic lymphocytic leukemia (CLL) patients who relapse after autologous stem cell transplantation (ASCT)
    Trisolini, SM
    Mauro, FR
    Capria, S
    Cimino, G
    De Propris, MS
    Proia, A
    Foa, R
    Meloni, G
    [J]. BLOOD, 2004, 104 (11) : 388B - 388B
  • [45] MRD kinetics can predict the time to relapse after autologous stem cell transplantation (SCT) in chronic lymphocytic leukemia (CLL).
    Ritgen, M
    Boettcher, S
    Stilgenbauer, S
    Dohner, H
    Brueggeman, M
    Pott, C
    Raff, T
    Schmitz, N
    Hallek, M
    Kneba, M
    Dreger, P
    [J]. BLOOD, 2005, 106 (11) : 211A - 212A
  • [46] Early consolidation with rituximab after allogeneic stem cell transplantation with dose-reduced conditioning for chronic lymphocytic leukemia (CLL).
    Silling, G
    Scheffold, C
    Nolte, A
    Kroeger, MJ
    Niehues, S
    Zuehlsdorf, M
    Berdel, WE
    Kienast, J
    [J]. BLOOD, 2001, 98 (11) : 407A - 408A
  • [47] Autologous bone marrow transplantation in chronic lymphocytic leukemia (CLL)
    Mangoni, L
    Rizzoli, V
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1996, 50 (09) : 442 - 446
  • [48] Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia - a Multicentre Australian Experience: Prognostic Factors for Survival and Relapse
    Bajel, Ashish R.
    Curley, Cameron
    Lim, Andrew Boon Ming
    Handunnetti, Sasanka
    Getta, Bartlomiej
    Thompson, Philip A.
    Wright, Matthew P. F.
    Greenwood, Matthew
    Hertzberg, Mark S.
    Curtis, David J.
    Szer, Jeffrey
    Kennedy, Glen A.
    Ritchie, David
    [J]. BLOOD, 2014, 124 (21)
  • [49] Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status
    J Esteve
    N Villamor
    D Colomer
    F Cervantes
    E Campo
    E Carreras
    E Montserrat
    [J]. Leukemia, 2001, 15 : 445 - 451
  • [50] Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status
    Esteve, J
    Villamor, N
    Colomer, D
    Cervantes, F
    Campo, E
    Carreras, E
    Montserrat, E
    [J]. LEUKEMIA, 2001, 15 (03) : 445 - 451
12345